Skip to main content
. 2017 Jul 19;1(17):1312–1323. doi: 10.1182/bloodadvances.2017008227

Figure 1.

Figure 1.

Younger AML. OS comparisons between the (A) ts-AML and non–ts-AML population, (B) various prognostic risk groups including ts-AML, (C) ts-AML and t-AML, and (D) ts-AML based on whether patients had undergone transplant. chr, chromosome; SCT, allogeneic stem cell transplant; tot, total.